Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients

Clinical trial NCT07012330 · TERMINATED

Trial details

NCT number: NCT07012330
Sponsor: Erasmus Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine (NE) Tumors

Start date: 2007-03-01
Primary completion: 2013-12-31
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.